RFP: Syringe Services Program (SSP) Patient Navigation Demonstration Project

The opioid crisis has had substantial infectious disease consequences, particularly related to injection drug use (IDU). Comprehensive syringe services programs (SSPs), are a proven effective component of community-based programs preventing the spread of infectious disease from IDU. In 2019, the Centers for Disease Control and Prevention (CDC) appropriated $5 million for the Infectious Disease and the Opioid Epidemic initiative to respond to this public health threat. This three-year program will strengthen the capacity and improve the performance of SSPs throughout the United States by supporting enhanced technical assistance (TA) to ensure the provision of high-quality, comprehensive harm reduction services, and supporting the development and implementation of best practices for patient navigation from SSPs to community-based health and social services. Furthermore, this program will improve the capacity of SSPs to conduct process monitoring and evaluation to ensure their program goals and objectives are met, and it will demonstrate the usefulness and feasibility of a national IDU surveillance system to monitor drug use patterns, health consequences of IDU, and access to prevention and health services. These strategies and activities will strengthen capacity of organizations to implement comprehensive, sustainable SSPs, improve services provided, and improve national understanding of drug use patterns and access to prevention and intervention services to prevent infectious disease consequences of the opioid crisis.

NASTAD, in partnership with AIDS United, was selected to manage this grant-making and technical assistance initiative. In coordination with CDC, NASTAD is charged with soliciting, selecting, issuing, and monitoring subawards of $100,000 each to eight (8) sites to successfully build patient navigation programs that link clients of SSPs to community-based programs that address the medical and psychosocial needs of people who inject drugs (PWID), to effectively track navigation work and outcomes, and to develop guidance on replicating successes that can be used in the Harm Reduction TA toolkit that will result from this funding opportunity.

View the RFP: Syringe Services Program (SSP) Patient Navigation Demonstration Project Webinar here.